# Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease

> **NCT03067857** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Stem Cells Arabia** · enrollment: 40 (estimated)

## Conditions studied

- Motor Neuron Disease
- Amyotrophic Lateral Sclerosis
- Primary Lateral Sclerosis
- Progressive Muscular Atrophy
- Progressive Bulbar Palsies

## Interventions

- **BIOLOGICAL:** Stem Cells

## Key facts

- **NCT ID:** NCT03067857
- **Lead sponsor:** Stem Cells Arabia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2019-01
- **Final completion:** 2019-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2018-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03067857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03067857, "Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03067857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*